Cancer is smart.
Together, we can
be smarter.
Accelerating cancer research and improving the quality of care requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on a shared technology platform.
Together, we can learn from the experience of every patient.
For Community Oncology
OncoCloud is the most comprehensive suite of software and services in community oncology. Using our technology, community clinics are providing better care for patients while remaining efficient, independent and financially successful.
Learn more
For Life Sciences
With access to billions of data points on millions of cancer patients treated across our network, Flatiron is changing the way life science companies are using real-world data to accelerate research and generate evidence.
Learn more
For Academics & Hospitals
Flatiron’s enriched data infrastructure helps hospitals and academic centers unlock the promise of their EHR data. Researchers and clinicians now have access to research-grade insights from within and beyond the walls of their institution.
Learn moreDo well by doing good. Join the leading cancer technology company.
Life at Flatiron
The talent and dedication of the people working at Flatiron makes everything we do possible. If you’re passionate about having an impact on cancer research and patient care, we’d love to hear from you.
Open positionsLet us tell you more.
We will email you to start the conversation.
Our Journey to Integrating Real-World Clinical Outcomes and Genomics
How we built a real-world clinico genomic database to yield novel and clinically meaningful insights.
Flatiron Health’s OncoEMR is Top-Rated for Overall Satisfaction by KLAS’ 2019 Medical Oncology Performance Report
OncoEMR has been top-rated in overall satisfaction by KLAS Research in the 2019 Medical Oncology Report.
The FDA and Flatiron Health Expand Real-World Data Cancer Research Collaboration
The expanded collaboration will continue to focus on critical topics related to the use of RWE in regulatory decision-making.